WELLS FARGO & COMPANY/MN - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,296,425
-30.2%
47,023
-23.9%
0.00%
-100.0%
Q2 2023$1,857,527
-0.9%
61,794
+19.5%
0.00%0.0%
Q1 2023$1,873,924
+26.2%
51,723
+24.2%
0.00%
Q4 2022$1,485,049
-11.3%
41,633
-15.8%
0.00%
-100.0%
Q3 2022$1,674,000
+8.7%
49,458
-7.1%
0.00%
Q2 2022$1,540,000
-55.2%
53,264
-50.0%
0.00%
-100.0%
Q1 2022$3,440,000
-0.7%
106,438
-10.4%
0.00%0.0%
Q4 2021$3,463,000
-8.8%
118,766
-16.6%
0.00%0.0%
Q3 2021$3,798,000
-1.4%
142,407
+13.8%
0.00%0.0%
Q2 2021$3,852,000
-30.7%
125,111
-41.0%
0.00%0.0%
Q1 2021$5,555,000
+65.6%
212,176
+59.1%
0.00%0.0%
Q4 2020$3,354,000
+14.4%
133,319
-5.2%
0.00%0.0%
Q3 2020$2,931,000
-4.1%
140,567
+9.3%
0.00%0.0%
Q2 2020$3,055,000
+42.7%
128,651
+8.1%
0.00%0.0%
Q1 2020$2,141,000
-43.1%
119,029
-25.0%
0.00%0.0%
Q4 2019$3,766,000
-33.7%
158,754
-23.2%
0.00%
-50.0%
Q3 2019$5,680,000
-38.2%
206,651
-25.7%
0.00%
-33.3%
Q2 2019$9,198,000
-29.1%
277,977
-24.9%
0.00%
-25.0%
Q1 2019$12,966,000
-36.1%
370,010
-39.4%
0.00%
-42.9%
Q4 2018$20,286,000
-49.2%
610,635
-23.1%
0.01%
-36.4%
Q3 2018$39,962,000
-30.2%
793,683
-17.1%
0.01%
-35.3%
Q2 2018$57,290,000
+39.6%
957,210
+6.8%
0.02%
+41.7%
Q1 2018$41,041,000
+36.3%
896,110
+18.6%
0.01%
+33.3%
Q4 2017$30,105,000
+22.3%
755,422
+22.7%
0.01%
+12.5%
Q3 2017$24,624,000
-13.6%
615,584
-6.9%
0.01%
-11.1%
Q2 2017$28,501,000
+77.5%
661,275
+28.9%
0.01%
+80.0%
Q1 2017$16,057,000
+25.0%
513,009
+0.8%
0.01%0.0%
Q4 2016$12,847,000
+9.6%
508,768
+7.3%
0.01%
+25.0%
Q3 2016$11,724,000
+6.8%
474,076
-12.1%
0.00%0.0%
Q2 2016$10,982,000
+29.1%
539,104
-3.4%
0.00%
+33.3%
Q1 2016$8,507,000
+22.5%
557,834
+7.9%
0.00%0.0%
Q4 2015$6,945,000
+7.7%
516,784
+12.5%
0.00%0.0%
Q3 2015$6,447,000
-20.5%
459,426
-3.9%
0.00%0.0%
Q2 2015$8,114,000
-7.2%
477,842
-33.9%
0.00%
+50.0%
Q1 2015$8,740,000
+231.4%
722,628
+127.4%
0.00%
+100.0%
Q4 2014$2,637,000
+21875.0%
317,726
+23487.7%
0.00%
Q3 2014$12,000
-55.6%
1,347
-46.0%
0.00%
Q2 2014$27,0002,494
+7945.2%
0.00%
Q4 2013$0310.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders